Columbus-based Priority One Canine (P1K9), known worldwide for their elite canine protection force, has acquired Alabama-based Bio Detection K9 alongside the creation of a joint venture with French biotechnology company Neovacs to use emerging technology to elevate canine services and security.
"We are thrilled to have formed a joint venture with France-based Neovacs, continuing the efforts of the French government to deploy a national program for COVID-19 detection using K9 assets," said Wade Morrell, CEO of P1K9. "Seven years after our first appearance on Shark Tank as a startup, and millions of dollars in sales later, P1K9 is extremely proud to close this deal with the support of this COVID-focused biotechnology company."
Bio Detection K9 specializes in the scientific research, development and implementation of canine detection services that address current threats such as COVID-19 and emerging threats of additional biological contagions. The company intends to deploy COVID detecting K9 assets around the world, which will allow the general population to resume life in which they can safely attend much-needed social gatherings and sporting events.
